World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application
SHANGHAI, May 9, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its independently...
CL Workshop Group Limited Receives Nasdaq Notice of Bid Price Deficiency
NEW YORK, May 8, 2026 /PRNewswire/ -- CL Workshop Group Limited (Nasdaq: NWGL) (the "Company"), a global forestry company that focuses on the timber and wood products industry, today announced that it received a notification letter dated May 6, 2026...
AeC Receives Frost & Sullivan's 2026 Brazilian Customer Experience Management Company of the Year Recognition
Recognized for its visionary innovation and disciplined growth, delivering exceptional customer satisfaction and operational excellence in Brazil's evolving landscape. SAN ANTONIO, May 7, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to...
BostonGene Receives Frost & Sullivan's 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Recognition highlights BostonGene's leadership in improving drug development decisions, reducing risk and accelerating patient impact SAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that BostonGene has been...
Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy improvements, the inhalation solution has received IND clearance from the CDE. The inhalation...
C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)
DMF No. 43568 is now active and available for reference in global IND and NDA submissions CHENGDU, China, April 28, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu) Co., Ltd., today announced that its Type II Drug Master File (DMF) for COPPER...
Centrical Receives Frost & Sullivan's 2026 Global Transformational Innovation Leadership Recognition for Excellence in Performance Intelligence
Recognized for advancing performance intelligence through transformational innovation that enhances frontline productivity, engagement, and business outcomes. SAN ANTONIO, April 28, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce...
Ivonescimab Receives Major Recommendations Across Multiple Therapies in the 2026 CSCO NSCLC Guideline
HONG KONG, April 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that ivonescimab, the company's first-in-class PD-1/VEGF bispecific antibody, has secured multiple authoritative updates and upgrades across...
Grundfos Pumps India Receives Frost & Sullivan's 2026 Indian Company of the Year Recognition for Leadership in Sustainable Pumps for Industrial Water
The recognition highlights Grundfos Pumps India's market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship. SAN ANTONIO, April 28, 2026 /PRNewswire/ --...
3Shape Receives FDA 510(k) Clearance for 3Shape Dx Software
COPENHAGEN, Denmark, April 28, 2026 /PRNewswire/ -- 3Shape today announced that the U.S. Food and Drug Administration (FDA) has granted FDA clearance for its Dx Software following a review completed on April 10. 2026. The 510(k) Premarket...